Literature DB >> 24599793

Impairments in brain-derived neurotrophic factor-induced glutamate release in cultured cortical neurons derived from rats with intrauterine growth retardation: possible involvement of suppression of TrkB/phospholipase C-γ activation.

Tadahiro Numakawa1, Tomoya Matsumoto, Yoshiko Ooshima, Shuichi Chiba, Miyako Furuta, Aiko Izumi, Midori Ninomiya-Baba, Haruki Odaka, Kazuo Hashido, Naoki Adachi, Hiroshi Kunugi.   

Abstract

Low birth weight due to intrauterine growth retardation (IUGR) is suggested to be a risk factor for various psychiatric disorders such as schizophrenia. It has been reported that developmental cortical dysfunction and neurocognitive deficits are observed in individuals with IUGR, however, the underlying molecular mechanisms have yet to be elucidated. Brain-derived neurotrophic factor (BDNF) and its receptor TrkB are associated with schizophrenia and play a role in cortical development. We previously demonstrated that BDNF induced glutamate release through activation of the TrkB/phospholipase C-γ (PLC-γ) pathway in developing cultured cortical neurons, and that, using a rat model for IUGR caused by maternal administration of thromboxane A2, cortical levels of TrkB were significantly reduced in IUGR rats at birth. These studies prompted us to hypothesize that TrkB reduction in IUGR cortex led to impairment of BDNF-dependent glutamatergic neurotransmission. In the present study, we found that BDNF-induced glutamate release was strongly impaired in cultured IUGR cortical neurons where TrkB reduction was maintained. Impairment of BDNF-induced glutamate release in IUGR neurons was ameliorated by transfection of human TrkB (hTrkB). Although BDNF-stimulated phosphorylation of TrkB and of PLC-γ was decreased in IUGR neurons, the hTrkB transfection recovered the deficits in their phosphorylation. These results suggest that TrkB reduction causes impairment of BDNF-stimulated glutamatergic function via suppression of TrkB/PLC-γ activation in IUGR cortical neurons. Our findings provide molecular insights into how IUGR links to downregulation of BDNF function in the cortex, which might be involved in the development of IUGR-related diseases such as schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24599793     DOI: 10.1007/s11064-014-1270-x

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  24 in total

1.  EEG at 6 weeks of life in very premature neonates.

Authors:  Daniele Selton; Monique André; Chantal Debruille; Helene Deforge; Jeanne Fresson; Jean-Michel Hascoet
Journal:  Clin Neurophysiol       Date:  2010-03-29       Impact factor: 3.708

2.  Birth weight and neurocognition in schizophrenia spectrum disorders.

Authors:  David Freedman; Yuanyuan Bao; William S Kremen; Sophia Vinogradov; Ian W McKeague; Alan S Brown
Journal:  Schizophr Bull       Date:  2012-02-29       Impact factor: 9.306

3.  Neuropathological changes in the cerebrum of IUGR rat induced by synthetic thromboxane A2.

Authors:  M Hayakawa; S Mimura; J Sasaki; K Watanabe
Journal:  Early Hum Dev       Date:  1999-06       Impact factor: 2.079

4.  Birth weight, schizophrenia, and adult mental disorder: is risk confined to the smallest babies?

Authors:  Kathryn M Abel; Susanne Wicks; Ezra S Susser; Christina Dalman; Marianne G Pedersen; Preben Bo Mortensen; Roger T Webb
Journal:  Arch Gen Psychiatry       Date:  2010-09

5.  Cortical neurons from intrauterine growth retardation rats exhibit lower response to neurotrophin BDNF.

Authors:  Midori Ninomiya; Tadahiro Numakawa; Naoki Adachi; Miyako Furuta; Shuichi Chiba; Misty Richards; Shigenobu Shibata; Hiroshi Kunugi
Journal:  Neurosci Lett       Date:  2010-04-14       Impact factor: 3.046

6.  Fetal growth and schizophrenia: a nested case-control and case-sibling study.

Authors:  Philip Rising Nielsen; Preben Bo Mortensen; Christina Dalman; Tine Brink Henriksen; Marianne Giørtz Pedersen; Carsten Bøcker Pedersen; Esben Agerbo
Journal:  Schizophr Bull       Date:  2012-12-12       Impact factor: 9.306

7.  Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia.

Authors:  C S Weickert; D L Ligons; T Romanczyk; G Ungaro; T M Hyde; M M Herman; D R Weinberger; J E Kleinman
Journal:  Mol Psychiatry       Date:  2005-07       Impact factor: 15.992

8.  The release of glutamate from cortical neurons regulated by BDNF via the TrkB/Src/PLC-γ1 pathway.

Authors:  Zitao Zhang; Jin Fan; Yongxin Ren; Wei Zhou; Guoyong Yin
Journal:  J Cell Biochem       Date:  2013-01       Impact factor: 4.429

9.  Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia.

Authors:  Tadahiro Numakawa; Yuki Yagasaki; Tetsuya Ishimoto; Takeya Okada; Tatsuyo Suzuki; Nakao Iwata; Norio Ozaki; Takahisa Taguchi; Masahiko Tatsumi; Kunitoshi Kamijima; Richard E Straub; Daniel R Weinberger; Hiroshi Kunugi; Ryota Hashimoto
Journal:  Hum Mol Genet       Date:  2004-09-02       Impact factor: 6.150

10.  Extracellular domain of neurotrophin receptor trkB: disulfide structure, N-glycosylation sites, and ligand binding.

Authors:  M Haniu; J Talvenheimo; J Le; V Katta; A Welcher; M F Rohde
Journal:  Arch Biochem Biophys       Date:  1995-09-10       Impact factor: 4.013

View more
  2 in total

1.  In SilicoModel-driven Assessment of the Effects of Brain-derived Neurotrophic Factor Deficiency on Glutamate and Gamma-Aminobutyric Acid: Implications for Understanding Schizophrenia Pathophysiology.

Authors:  Rimjhim Agrawal; Sunil Vasu Kalmady; Ganesan Venkatasubramanian
Journal:  Clin Psychopharmacol Neurosci       Date:  2017-05-31       Impact factor: 2.582

2.  Electroacupuncture ameliorate learning and memory by improving N-acetylaspartate and glutamate metabolism in APP/PS1 mice.

Authors:  Ruhui Lin; Long Li; Yingzheng Zhang; Sheng Huang; Shangjie Chen; Jiao Shi; Peiyuan Zhuo; Hao Jin; Zuanfang Li; Weilin Liu; Zhifu Wang; Lidian Chen; Jing Tao
Journal:  Biol Res       Date:  2018-07-06       Impact factor: 5.612

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.